114 related articles for article (PubMed ID: 38884419)
1. Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations.
Zhang T; Han Y; Huang W; Wei H; Zhao Y; Shu L; Guo Y; Ye B; Zhou J; Liu J
J Med Virol; 2024 Jun; 96(6):e29743. PubMed ID: 38884419
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
5. Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.
Ursin RL; Liu H; Powell HR; Westerbeck JW; Shaw-Saliba K; Sylvia KE; Fenstermacher KJ; Mehoke T; Thielen P; Rothman RE; Pekosz A; Klein SL
J Infect Dis; 2020 Sep; 222(8):1371-1382. PubMed ID: 32496543
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
[TBL] [Abstract][Full Text] [Related]
7. Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.
Zhu H; Lee ACY; Li C; Mak WWN; Chen YY; Chan KH; Zhang AJX; Fung WF; Zhang RQ; Fung YF; Poon RWS; Lam JY; Tam S; Hung IFN; Chen H; Yuen KY; To KKW
Emerg Microbes Infect; 2018 Mar; 7(1):23. PubMed ID: 29511175
[TBL] [Abstract][Full Text] [Related]
8. Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.
Liu F; Gross FL; Jefferson SN; Holiday C; Bai Y; Wang L; Zhou B; Levine MZ
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690218
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
van der Velden MV; Geisberger A; Dvorak T; Portsmouth D; Fritz R; Crowe BA; Herr W; Distler E; Wagner EM; Zeitlinger M; Sauermann R; Stephan C; Ehrlich HJ; Barrett PN; Aichinger G
Clin Vaccine Immunol; 2014 Jun; 21(6):867-76. PubMed ID: 24739978
[TBL] [Abstract][Full Text] [Related]
10. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
[TBL] [Abstract][Full Text] [Related]
11. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
12. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
13. Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.
Kosikova M; Li L; Radvak P; Ye Z; Wan XF; Xie H
Clin Infect Dis; 2018 Oct; 67(10):1523-1532. PubMed ID: 29672713
[TBL] [Abstract][Full Text] [Related]
14. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
[TBL] [Abstract][Full Text] [Related]
16. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD
Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912
[TBL] [Abstract][Full Text] [Related]
18. Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine.
Qiu C; Huang Y; Wang Q; Tian D; Zhang W; Hu Y; Yuan Z; Zhang X; Xu J
Clin Infect Dis; 2012 Jan; 54(1):17-24. PubMed ID: 22052887
[TBL] [Abstract][Full Text] [Related]
19. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
Houser KV; Pearce MB; Katz JM; Tumpey TM
J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569
[TBL] [Abstract][Full Text] [Related]
20. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
Front Immunol; 2018; 9():2465. PubMed ID: 30405641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
